Generation Bio Co. Statistics
Total Valuation
GBIO has a market cap or net worth of $191.60 million. The enterprise value is $66.06 million.
Market Cap | 191.60M |
Enterprise Value | 66.06M |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
Earnings Date | Jul 31, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GBIO has 66.53 million shares outstanding. The number of shares has increased by 10.30% in one year.
Shares Outstanding | 66.53M |
Shares Change (YoY) | +10.30% |
Shares Change (QoQ) | +0.54% |
Owned by Insiders (%) | 14.56% |
Owned by Institutions (%) | 83.41% |
Float | 48.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 19.23 |
Forward PS | 27.91 |
PB Ratio | 1.45 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 6.63 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.01, with a Debt / Equity ratio of 0.73.
Current Ratio | 8.01 |
Quick Ratio | n/a |
Debt / Equity | 0.73 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -82.30% and return on invested capital (ROIC) is -79.55%.
Return on Equity (ROE) | -82.30% |
Return on Assets (ROA) | -46.70% |
Return on Capital (ROIC) | -79.55% |
Revenue Per Employee | $57,259 |
Profits Per Employee | -$971,603 |
Employee Count | 174 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.75% in the last 52 weeks. The beta is 2.84, so GBIO's price volatility has been higher than the market average.
Beta (5Y) | 2.84 |
52-Week Price Change | -43.75% |
50-Day Moving Average | 2.99 |
200-Day Moving Average | 2.46 |
Relative Strength Index (RSI) | 51.61 |
Average Volume (20 Days) | 154,757 |
Short Selling Information
The latest short interest is 1.68 million, so 2.53% of the outstanding shares have been sold short.
Short Interest | 1.68M |
Short Previous Month | 1.52M |
Short % of Shares Out | 2.53% |
Short % of Float | 3.46% |
Short Ratio (days to cover) | 10.54 |
Income Statement
In the last 12 months, GBIO had revenue of $9.96 million and -$169.06 million in losses. Loss per share was -$2.55.
Revenue | 9.96M |
Gross Profit | 9.96M |
Operating Income | -181.33M |
Pretax Income | -169.06M |
Net Income | -169.06M |
EBITDA | -163.81M |
EBIT | -169.06M |
Loss Per Share | -$2.55 |
Balance Sheet
The company has $221.49 million in cash and $95.95 million in debt, giving a net cash position of $125.54 million or $1.89 per share.
Cash & Cash Equivalents | 221.49M |
Total Debt | 95.95M |
Net Cash | 125.54M |
Net Cash Per Share | $1.89 |
Equity (Book Value) | 131.99M |
Book Value Per Share | 1.98 |
Working Capital | 198.54M |
Cash Flow
In the last 12 months, operating cash flow was -$56.77 million and capital expenditures -$8.56 million, giving a free cash flow of -$65.33 million.
Operating Cash Flow | -56.77M |
Capital Expenditures | -8.56M |
Free Cash Flow | -65.33M |
FCF Per Share | -$0.98 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,820.04% and -1,696.87%.
Gross Margin | 100.00% |
Operating Margin | -1,820.04% |
Pretax Margin | -1,696.87% |
Profit Margin | -1,696.87% |
EBITDA Margin | -1,644.22% |
EBIT Margin | -1,696.87% |
FCF Margin | -655.68% |
Dividends & Yields
GBIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.30% |
Shareholder Yield | -10.30% |
Earnings Yield | -88.23% |
FCF Yield | -34.09% |
Analyst Forecast
The average price target for GBIO is $8.00, which is 177.78% higher than the current price. The consensus rating is "Buy".
Price Target | $8.00 |
Price Target Difference | 177.78% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 13.14% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
GBIO has an Altman Z-Score of -3.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.5 |
Piotroski F-Score | 1 |